Journal of Clinical Monitoring and Computing

, Volume 24, Issue 4, pp 251–259 | Cite as

Flow cytometry and laser scanning cytometry, a comparison of techniques

  • William J. Mach
  • Amanda R. Thimmesch
  • James A. Orr
  • Joyce G. Slusser
  • Janet D. Pierce



Flow and laser scanning cytometry are used extensively in research and clinical settings. These techniques provide clinicians and scientists information about cell functioning in a variety of health and disease states. An in-depth knowledge and understanding of cytometry techniques can enhance interpretation of current research findings. Our goal with this review is to reacquaint clinicians and scientists with information concerning differences between flow and laser scanning cytometry by comparing their capabilities and applications.


A Pubmed abstract search was conducted for articles on research, reviews and current texts relating to origins and use of flow and laser scanning cytometry. Attention was given to studies describing application of these techniques in the clinical setting.


Both techniques exploit interactions between the physical properties of light. Data are immediately and automatically acquired; they are distinctly different. Flow cytometry provides valuable rapid information about a wide variety of cellular or particle characteristics. This technique does not provide the scanned high resolution image analysis needed for investigators to localize areas of interest within the cell for quantification. Flow cytometry requires that the sample contain a large amount disaggregated, single, suspended cells. Laser scanning cytometry is slide-based and does not require as large of a sample. The tissue sample is affixed to a slide allowing repeated sample analyses. These cytometry techniques are used in the clinical setting to understand pathophysiological derangements associated with many diseases; cardiovascular disease, diabetes, acute lung injury, hemorrhagic shock, surgery, cancer and Alzheimer’s disease.


Understanding the dif- ferences between FCM and LSCM can assist investigators in planning and design of their research or clinical testing. Researchers and clinicians optimize these technique capa- bilities with the cellular characteristics they wish to measure delineating molecular and cellular events occurring in health and disease. Discovery of mechanisms in cells using FCM and LSCM provide evidence needed to guide future treatment and interventions.


flow cytometry laser scanning cytometry fluorescence 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.



This project was sponsored by the TriService Nursing Research Program (N09-012, HU 0001-08-1-TS08). The information or content and conclusions do not necessarily represent the official position or policy of, nor should any official endorsement be inferred by, the TriService Nursing Research Program, the Department of Defense, or the US Government.


  1. 1.
    Tarnok A, Gerstner AO. Clinical applications of laser scanning cytometry. Cytometry. 2002;50(3):133–43.CrossRefPubMedGoogle Scholar
  2. 2.
    Pozarowski P, Holden E, Darzynkiewicz Z. Laser scanning cytometry: principles and applications. Methods Mol Biol. 2006;319:165–92.CrossRefPubMedGoogle Scholar
  3. 3.
    Valet G. Past and present concepts in flow cytometry: a European perspective. J Biol Regul Homeost Agents. 2003;17(3):213–22.PubMedGoogle Scholar
  4. 4.
    Darzynkiewicz Z, Crissman H, Jacobberger JW. Cytometry of the cell cycle: cycling through history. Cytometry A. 2004;58(1):21–32.CrossRefPubMedGoogle Scholar
  5. 5.
    Kamentsky LA. Laser scanning cytometry. Methods Cell Biol. 2001;63:51–87.CrossRefPubMedGoogle Scholar
  6. 6.
    Nolan JP, Yang L. The flow of cytometry into systems biology. Brief Funct Genomic Proteomic. 2007;6(2):81–90.CrossRefPubMedGoogle Scholar
  7. 7.
    Shapiro H. Practical flow cytometry. 4th ed. Hoboken: Willey-Liss; 2003.Google Scholar
  8. 8.
    Rieseberg M, Kasper C, Reardon KF, Scheper T. Flow cytometry in biotechnology. Appl Microbiol Biotechnol. 2001;56(3–4):350–60.CrossRefPubMedGoogle Scholar
  9. 9.
    Cram LS. Flow cytometry, an overview. Methods Cell Sci. 2002;24(1–3):1–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Luther E, Kamentsky L, Henriksen M, Holden E. Next-generation laser scanning cytometry. Methods Cell Biol. 2004;75:185–218.CrossRefPubMedGoogle Scholar
  11. 11.
    Kamentsky LA, Burger DE, Gershman RJ, Kamentsky LD, Luther E. Slide-based laser scanning cytometry. Acta Cytol. 1997;41(1):123–43.PubMedGoogle Scholar
  12. 12.
    Kamentsky LA, Kamentsky LD, Fletcher JA, Kurose A, Sasaki K. Methods for automatic multiparameter analysis of fluorescence in situ hybridized specimens with a laser scanning cytometer. Cytometry. 1997;27(2):117–25.CrossRefPubMedGoogle Scholar
  13. 13.
    Darzynkiewicz Z, Bedner E, Li X, Gorczyca W, Melamed MR. Laser-scanning cytometry: a new instrumentation with many applications. Exp Cell Res. 1999;249(1):1–12.CrossRefPubMedGoogle Scholar
  14. 14.
    Wijsman JA, Obert LA, Paulissen J, Garrido R, Toy KA, Dunstan RW. A practical method to determine the amount of tissue to analyze using laser scanning cytometry. Cytometry A. 2007;71(7):501–8.PubMedGoogle Scholar
  15. 15.
    Cram LS, Arndt-Jovin D. Mack Jett Fulwyler, pioneer of flow cytometry and flow sorting (1936–2001). Cytometry A. 2005;67(2):53–4. cover.PubMedGoogle Scholar
  16. 16.
    Mittag A, Lenz D, Gerstner AO, Tarnok A. Hyperchromatic cytometry principles for cytomics using slide based cytometry. Cytometry A. 2006;69(7):691–703.PubMedGoogle Scholar
  17. 17.
    Oswald J, Jorgensen B, Pompe T, et al. Comparison of flow cytometry and laser scanning cytometry for the analysis of CD34+ hematopoietic stem cells. Cytometry A. 2004;57(2):100–7.CrossRefPubMedGoogle Scholar
  18. 18.
    Bedner E, Burfeind P, Gorczyca W, Melamed MR, Darzynkiewicz Z. Laser scanning cytometry distinguishes lymphocytes, monocytes, and granulocytes by differences in their chromatin structure. Cytometry. 1997;29(3):191–6.CrossRefPubMedGoogle Scholar
  19. 19.
    Holden JA. DNA topoisomerases as anticancer drug targets: from the laboratory to the clinic. Curr Med Chem Anticancer Agents. 2001;1(1):1–25.CrossRefPubMedGoogle Scholar
  20. 20.
    Pozarowski P, Darzynkiewicz Z. Analysis of cell cycle by flow cytometry. Methods Mol Biol. 2004;281:301–11.PubMedGoogle Scholar
  21. 21.
    Vermes I, Haanen C, Reutelingsperger C. Flow cytometry of apoptotic cell death. J Immunol Methods. 2000;243(1–2):167–90.CrossRefPubMedGoogle Scholar
  22. 22.
    Bedner E, Li X, Gorczyca W, Melamed MR, Darzynkiewicz Z. Analysis of apoptosis by laser scanning cytometry. Cytometry. 1999;35(3):181–95.CrossRefPubMedGoogle Scholar
  23. 23.
    Darzynkiewicz Z, Bedner E, Traganos F, Murakami T. Critical aspects in the analysis of apoptosis and necrosis. Hum Cell. 1998;11(1):3–12.PubMedGoogle Scholar
  24. 24.
    Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T, Traganos F. Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry. 1997;27(1):1–20.CrossRefPubMedGoogle Scholar
  25. 25.
    Matyus AE. Flow cytometry and cell sorting (Vol. 1: Techniques). New York: Plenum Press; 1991.Google Scholar
  26. 26.
    DeRosa S, Benchley J, Roederer M. Beyond six colors: a new era in flow cytometry. Nat Med. 2003;9(1):112–7.CrossRefGoogle Scholar
  27. 27.
    Deptala A, Bedner E, Darzynkiewicz Z. Unique analytical capabilities of laser scanning cytometry (LSC) that complement flow cytometry. Folia Histochem Cytobiol. 2001;39(2):87–9.PubMedGoogle Scholar
  28. 28.
    Herzenberg LA, Tung J, Moore WA, Parks DR. Interpreting flow cytometry data: a guide for the perplexed. Nat Immunol. 2006;7(7):681–5.CrossRefPubMedGoogle Scholar
  29. 29.
    Roederer M, Darzynkiewicz Z, Parks DR. Guidelines for the presentation of flow cytometric data. Methods Cell Biol. 2004;75:241–56.CrossRefPubMedGoogle Scholar
  30. 30.
    Wood JC, Hoffman RA. Evaluating fluorescence sensitivity on flow cytometers: an overview. Cytometry. 1998;33(2):256–9.CrossRefPubMedGoogle Scholar
  31. 31.
    Brown M, Wittwer C. Flow cytometry: principles and clinical applications in hematology. Clin Chem. 2000;46(8 Pt 2):1221–9.PubMedGoogle Scholar
  32. 32.
    Bigalke B, Stellos K, Stakos D, et al. Influence of platelet count on the expression of platelet collagen receptor glycoprotein VI (GPVI) in patients with acute coronary syndrome. Thromb Haemost. 2009;101(5):911–5.PubMedGoogle Scholar
  33. 33.
    Fox SC, May JA, Shah A, Neubert U, Heptinstall S. Measurement of platelet P-selectin for remote testing of platelet function during treatment with clopidogrel and/or aspirin. Platelets. 2009;20(4):250–9.CrossRefPubMedGoogle Scholar
  34. 34.
    Sibal, L., Aldibbiat, A., Agarwal, S.C., et al. Circulating endothelial progenitor cells, endothelial function, carotid intima-media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuria. Diabetologia 2009; 52(8): 1464–1473Google Scholar
  35. 35.
    Taatjes DJ, Wadsworth MP, Quinn AS, Rand JH, Bovill EG, Sobel BE. Imaging aspects of cardiovascular disease at the cell and molecular level. Histochem Cell Biol. 2008;130(2):235–45.CrossRefPubMedGoogle Scholar
  36. 36.
    Schneider DJ, Hayes M, Wadsworth M, et al. Attenuation of neointimal vascular smooth muscle cellularity in atheroma by plasminogen activator inhibitor type 1 (PAI-1). J Histochem Cytochem. 2004;52(8):1091–9.CrossRefPubMedGoogle Scholar
  37. 37.
    Kolackova M, Kudlova M, Kunes P, et al. Early expression of FcgammaRI (CD64) on monocytes of cardiac surgical patients and higher density of monocyte anti-inflammatory scavenger CD163 receptor in “on-pump” patients. Mediators Inflamm 2008;235461.Google Scholar
  38. 38.
    Ritter L, Funk J, Schenkel L, et al. Inflammatory and hemodynamic changes in the cerebral microcirculation of aged rats after global cerebral ischemia and reperfusion. Microcirculation. 2008;15(4):297–310.CrossRefPubMedGoogle Scholar
  39. 39.
    Vega D, Badami CD, Caputo FJ, et al. The influence of the type of resuscitation fluid on gut injury and distant organ injury in a rat model of trauma/hemorrhagic shock. J Trauma. 2008;65(2):409–14. discussion 414–405.CrossRefPubMedGoogle Scholar
  40. 40.
    Jones R, Capen DE, Jacobson M, Cohen KS, Scadden DT, Duda DG. VEGFR2PDGFRbeta circulating precursor cells participate in capillary restoration after hyperoxia acute lung injury (HALI). J Cell Mol Med 2009; 13(9B), 3720–3729.Google Scholar
  41. 41.
    Suzuki Y, Nishio K, Takeshita K, et al. Effect of steroid on hyperoxia-induced ICAM-1 expression in pulmonary endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2000;278(2):L245–52.PubMedGoogle Scholar
  42. 42.
    Chang LT, Sun CK, Chiang CH, Wu CJ, Chua S, Yip HK. Impact of simvastatin and losartan on antiinflammatory effect: in vitro study. J Cardiovasc Pharmacol. 2007;49(1):20–6.CrossRefPubMedGoogle Scholar
  43. 43.
    Buder-Hoffmann S, Palmer C, Vacek P, Taatjes D, Mossman B. Different accumulation of activated extracellular signal-regulated kinases (ERK 1/2) and role in cell-cycle alterations by epidermal growth factor, hydrogen peroxide, or asbestos in pulmonary epithelial cells. Am J Respir Cell Mol Biol. 2001;24(4):405–13.PubMedGoogle Scholar
  44. 44.
    Jin D, Port J, Korst R. Lee P, Li Z, McDonald K, Ferrara C, Meherally D, Rafii S, Altorki N. Surgical resection normalizes the hemangiogenic profile in patients with non-small cell lung cancer. Paper presented at the American Association for Thoracic Surgery. 2007.Google Scholar
  45. 45.
    Ishikawa M, Nishioka M, Hanaki N, et al. Perioperative immune responses in cancer patients undergoing digestive surgeries. World J Surg Oncol. 2009;7:7.CrossRefPubMedGoogle Scholar
  46. 46.
    Park MS, Lee HM, Hahn SB, et al. The association of the activation-inducible tumor necrosis factor receptor and ligand with lumbar disc herniation. Yonsei Med J. 2007;48(5):839–46.CrossRefPubMedGoogle Scholar
  47. 47.
    Henry M, Davidson L, Cohen Z, McDonagh PF, Nolan PE, Ritter LS. Whole blood aggregation, coagulation, and markers of platelet activation in diet-induced diabetic C57BL/6J mice. Diabetes Res Clin Pract. 2009;84(1):11–8.CrossRefPubMedGoogle Scholar
  48. 48.
    Chen JZ, Zhang FR, Tao QM, Wang XX, Zhu JH. Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia. Clin Sci (Lond). 2004;107(3):273–80.CrossRefGoogle Scholar
  49. 49.
    Turina M, Miller FN, Tucker CF, Polk HC. Short-term hyperglycemia in surgical patients and a study of related cellular mechanisms. Ann Surg. 2006;243(6):845–51. discussion 851–843.CrossRefPubMedGoogle Scholar
  50. 50.
    Yow CM, Chen JY, Mak NK, Cheung NH, Leung AW. Cellular uptake, subcellular localization and photodamaging effect of temoporfin (mTHPC) in nasopharyngeal carcinoma cells: comparison with hematoporphyrin derivative. Cancer Lett. 2000;157(2):123–31.CrossRefPubMedGoogle Scholar
  51. 51.
    Paiva B, Vidriales MB, Cervero J, et al. Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation. Blood. 2008;112(10):4017–23.CrossRefPubMedGoogle Scholar
  52. 52.
    Al-Mawali A, Gillis D, Lewis I. The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia. Am J Clin Pathol. 2009;131(1):16–26.CrossRefPubMedGoogle Scholar
  53. 53.
    Landgren O, Albitar M, Ma W, et al. B-cell clones as early markers for chronic lymphocytic leukemia. N Engl J Med. 2009;360(7):659–67.CrossRefPubMedGoogle Scholar
  54. 54.
    Chen H, Sun B, Pan S, Jiang H, Sun X. Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo. Anticancer Drugs. 2009;20(2):131–40.CrossRefPubMedGoogle Scholar
  55. 55.
    Lu YY, Chen TS, Qu JL, Pan WL, Sun L, Wei XB. Dihydroartemisinin (DHA) induces caspase-3-dependent apoptosis in human lung adenocarcinoma ASTC-a-1 cells. J Biomed Sci. 2009;16:16.CrossRefPubMedGoogle Scholar
  56. 56.
    Ueno C, Fukatsu K, Kang W, et al. Route and type of nutrition influence nuclear factor kappaB activation in peritoneal resident cells. Shock. 2005;24(4):382–7.CrossRefPubMedGoogle Scholar
  57. 57.
    Tomita K, Chikumi H, Tokuyasu H, et al. Functional assay of NF-kappaB translocation into nuclei by laser scanning cytometry: inhibitory effect by dexamethasone or theophylline. Naunyn Schmiedebergs Arch Pharmacol. 1999;359(4):249–55.CrossRefPubMedGoogle Scholar
  58. 58.
    Zuba-Surma EK, Kucia M, Abdel-Latif A, Lillard JW Jr, Ratajczak MZ. The ImageStream System: a key step to a new era in imaging. Folia Histochem Cytobiol. 2007;45(4):279–90.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • William J. Mach
    • 1
  • Amanda R. Thimmesch
    • 1
  • James A. Orr
    • 2
  • Joyce G. Slusser
    • 3
  • Janet D. Pierce
    • 1
  1. 1.School of NursingUniversity of KansasKansas CityUSA
  2. 2.Department of Molecular BiosciencesUniversity of KansasLawrenceUSA
  3. 3.Flow Cytometry LaboratoryUniversity of KansasKansas CityUSA

Personalised recommendations